|
|
You Are On :
Home | Company Profile | Corporate Announcements
|
|
Corporate
Announcements
|
|
|
|
|
|
25-04-2024
|
|
|
ASTER DM HEALTHCARE LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
|
|
|
25-04-2024
|
|
|
Aster DM Healthcare Limited has informed the Exchange regarding Resignation of Mr Amitabh Johri as Chief Financial Officer of the company w.e.f. April 25, 2024. |
|
|
|
18-04-2024
|
|
|
Aster DM Healthcare Limited has informed the Exchange regarding Acquisition |
|
|
|
17-04-2024
|
|
|
Aster DM Healthcare Limited has informed the Exchange about Acquisition |
|
|
|
16-04-2024
|
|
|
Aster DM Healthcare Limited has informed the Exchange about Credit Rating |
|
|
|
16-04-2024
|
|
|
Aster DM Healthcare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
|
|
13-04-2024
|
|
|
ASTER DM HEALTHCARE LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 12-Apr-2024 for Dividend |
|
|
|
12-04-2024
|
|
|
Aster DM Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
|
|
|
12-04-2024
|
|
|
Aster DM Healthcare Limited has informed the Exchange that Board of Directors at its meeting held on April 12, 2024, declared Special Dividend of 118 per equity share. |
|
|
|
05-04-2024
|
|
|
ASTER DM HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 12-Apr-2024 to consider Dividend. |
|
|
|
05-04-2024
|
|
|
Aster DM Healthcare Limited has informed the Exchange that Record date for the purpose of Dividend is 23-Apr-2024. |
|
|
|
04-04-2024
|
|
|
ASTER DM HEALTHCARE LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
|
|
|
04-04-2024
|
|
|
ASTER DM HEALTHCARE LIMITED has informed the Exchange about Resignation of Independent director. |
|
|
|
03-04-2024
|
|
|
Aster DM Healthcare Limited has informed the Exchange regarding a press release dated April 03, 2024, titled "a) Update on disclosures made by the Company on March 28, 2022, June 11, 2022,November 10, 2022, February 14, 2023, July 05, 2023, July 24, 2023, November 28, 2023 andJanuary 23, 2024b) Press release on Aster DM Healthcare concludes separation of India and GCC businesses". |
|
|
|
03-04-2024
|
|
|
Aster DM Healthcare Limited has informed the Exchange regarding Resignation of Mr Daniel Robert Mintz as Non- Executive Director of the company w.e.f. April 03, 2024. |
|
|
|
03-04-2024
|
|
|
Aster DM Healthcare Limited has informed the Exchange regarding Resignation of Mr Wayne Earl Keathley as Non- Executive Independent Director of the company w.e.f. April 03, 2024. |
|
|
|
02-04-2024
|
|
|
Significant increase in volume has been observed in Aster DM Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Aster DM Healthcare Limited has submitted their response. |
|
|
|
28-03-2024
|
|
|
Significant increase in volume has been observed in Aster DM Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is saf |
|
|
|
28-03-2024
|
|
|
Significant increase in volume has been observed in Aster DM Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Aster DM Healthcare Limited has submitted their response. |
|
|
|
28-03-2024
|
|
|
Significant increase in volume has been observed in Aster DM Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |
|
|
|
|
|
|
|
|
|